DFM STUDENT SYLLABUS - Flipbook - Page 43
Pathophysiology: How SIBO and Gut Barrier Damage Drive Disease
555
The SIBO-Immune-Barrier Cascade
555
Initial Bacterial Overgrowth
555
Local Immune Activation
555
Barrier Compromise
555
Systemic Immune Effects
555
Potential Autoimmunity
555
The Vicious Cycle of SIBO
556
Motility Disruption
556
Bile Acid Disruption
556
Enzyme Insufficiency
556
Continued Barrier Damage
556
Conditions Where Array 22 is Especially Valuable
556
Primary Gut Disorders
556
Systemic Conditions with Gut Connections
557
Comprehensive Treatment Approaches Based on Array 22 Results
558
Bacterial Reduction
558
Pharmaceutical Antibiotics
558
Herbal Antimicrobials
558
Elemental Diets
558
Barrier Restoration
558
Targeted Nutrients
558
Specialized Barrier Formulations
559
Immune Modulation
559
Anti-inflammatory Support
559
Endotoxin Binders
559
Targeted Immunoglobulins
559
Motility Enhancement
559
Prokinetic Agents
559
Meal Timing
559
Vagal Nerve Support
559
Integration with Other Functional Testing
Complementary Cyrex Arrays
560
560
42
